BIOTRONIK is releasing a new line of MR-conditional pacemakers, the smallest the company has produced, and new quadripolar cardiac resynchronization therapy pacemakers (CRT-P). The Edora devices allow patients to receive MRI exams, as long as certain precautions are taken, and feature MRI AutoDetect feature that automatically puts an implant into safe mode when it’s near an MRI machine. When the scan is done and the patient moves away from the machine, the implant reverts back to its normal functionality.
All the Edoras also feature wireless connectivity, unloading its data to BIOTRONIK Home Monitoring system for the patient’s cardiologist to review at any time. The process is fully automatic, as long as the patient is near the Home Monitoring receiver once a day.
“With our new series of pacemakers, we can confidently say that small size, excellent longevity and a full set of features are no longer mutually exclusive,” commented Manuel Ortega, Senior Vice President at BIOTRONIK. “For both our pacemakers and our CRT-Ps, we have integrated the best of our technologies to offer patients a unique level of care.”
These devices are currently only approved for use in the European Economic Area and FDA regulatory green light is expected soon.